SCHEMBL6238329

SCHEMBL6238329

Cc1ccc(S(=O)(=O)OCCCCC(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
TSHR P16473 1/20 0.45
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 3/20 0.44
RAB9A P51151 1/20 0.44
PSMD10 O75832 1/20 0.44
TBXAS1 P24557 2/20 0.42
PPARG P37231 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.41
SIRT5 Q9NXA8 1/20 0.41
LTB4R Q15722 1/20 0.41
TBXA2R P21731 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8864017 0.98 STAT3 (0.46) STAT3L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL9458218 0.98 STAT3 (0.46) STAT3L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL30850377 0.98 STAT3 (0.46) STAT3L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL8863706 0.98 STAT3 (0.46) STAT3L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL17614843 0.98 STAT3 (0.46) STAT3L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL25030574 0.98 STAT3 (0.46) STAT3L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL7827739 0.98 STAT3 (0.46) STAT3L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL9764712 0.98 STAT3 (0.46) STAT3L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL10449020 0.98 STAT3 (0.46) STAT3L3MBTL1TSHRALDH1A1KMT2A
SCHEMBL7265145 0.95 TSHR (0.50) STAT3L3MBTL1TSHRALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019134765-A1 SARTAN ANALOGUE JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG (DE) 2019-07-11 WO disclosed
WO-2005023841-A1 NOVEL METHOD FOR THE SYNTHESIS OF PERINDOPRIL AND THE PHARMACEUTICALLY-ACCEPTABLE SALTS THEREOF LES LABORATOIRES SERVIER (FR) 2005-03-17 WO disclosed